Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours

Autor Baro, M, de Llobet, L I, Figueras, A, Skvortsova, I, Mesia, R, Balart, J
Vydáno 2014

Pleiotropic Effects of Epithelial Mesenchymal Crosstalk on Head and Neck Cancer: EMT and beyond

Autor Steinbichler, T. B., Savic, D., Dejaco, D., Romani, A., Kofler, B., Skvortsova, I. I., Riechelmann, H., Dudas, J.
Vydáno v Cancer Microenviron (2019)

Slug Is A Surrogate Marker of Epithelial to Mesenchymal Transition (EMT) in Head and Neck Cancer

Autor Steinbichler, T. B., Dudas, J., Ingruber, J., Glueckert, R., Sprung, S., Fleischer, F., Cidlinsky, N., Dejaco, D., Kofler, B., Giotakis, A. I., Skvortsova, I. I., Riechelmann, H.
Vydáno v J Clin Med (2020)

Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)

Autor Skvortsov, S, Dudás, J, Eichberger, P, Witsch-Baumgartner, M, Loeffler-Ragg, J, Pritz, C, Schartinger, V H, Maier, H, Hall, J, Debbage, P, Riechelmann, H, Lukas, P, Skvortsova, I
Vydáno 2014